Collaboration between researchers and clinicians at Dana-Farber/Brigham and Women’s Cancer Center heralds continuing success in the field of precision cancer medicine. The following team members play significant roles in both the lab and at the bedside as DF/BWCC continues to deliver on the promise of personalized medicine.
Noted Researchers and Clinicians
Monica M. Bertagnolli, MD
Chief, Division of Surgical Oncology, Department of Surgery, Brigham and Women’s Hospital; Professor of Surgery, Harvard Medical School
Lisa Diller, MD
Chief Medical Officer, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center; Clinical Director, Pediatric Oncology; Medical Director, Clinical Cancer and Blood Disorders Service Line; Medical Director, David B. Perini, Jr. Quality of Life Clinic
Levi Garraway, MD, PhD
Director, Joint Center for Cancer Precision Medicine Medical Oncologist; Center for Genitourinary Oncology, Dana-Farber/Brigham and Women’s Cancer Center; Senior Associate Member, Broad Institute; Associate Professor of Medicine, Harvard Medical School
Jeffrey Golden, MD
Chief Pathologist, Brigham and Women’s Hospital; Ramzi S. Cotran Professor of Pathology, Harvard Medical School
Katherine Janeway, MD
Solid Tumor Center at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center; Assistant Professor of Pediatrics, Harvard Medical School
Bruce Johnson, MD
Chief Clinical Research Officer, Dana-Farber Cancer Institute; Professor of Medicine, Harvard Medical School
Nancy Lin, MD
Clinical Director, Breast Oncology, Dana-Farber Cancer Institute; Assistant Professor of Medicine, Harvard Medical School
Matthew Meyerson, MD, PhD
Co-Director, Center for Cancer Genome Discovery; Professor of Pathology, Harvard Medical School
Barrett J. Rollins, MD, PhD
Chief Scientific Officer, Dana-Farber Cancer Institute; Linde Family Professor of Medicine, Harvard Medical School
Steven E. Seltzer, MD
Chairman, Department of Radiology, Brigham and Women’s Hospital; Professor, Harvard Medical School
Richard M. Stone, MD
Program Director, Adult Leukemia, Dana-Farber/Brigham and Women’s Cancer Center; Professor of Medicine, Harvard Medical School
Scott James Swanson, MD
Director of Minimally Invasive Thoracic Surgery, Brigham and Women’s Hospital; Chief Surgical Officer, Dana-Farber/Brigham and Women’s Cancer Center; Professor, Harvard Medical School
Michael J. Zinner, MD
Chairman, Department of Surgery, Brigham and Women’s Hospital
DF/BWCC Disease Center Leaders
Ross Berkowitz, MD
Director, Gynecologic Oncology, Dana-Farber/Brigham and Women’s Cancer Center; William H. Baker Professor of Gynecology, Harvard Medical School
Nancy Berliner, MD
Chief, Division of Adult Hematology, Dana-Farber/Brigham and Women’s Cancer Center; Professor of Medicine, Harvard Medical School
Susan Block MD
Chair, Department of Psychosocial Oncology and Palliative Care, Dana-Farber/Brigham and Women’s Cancer Center; Professor of Psychiatry and Medicine, Harvard Medical School
George D. Demetri, MD
Director, Center for Sarcoma and Bone Oncology, Dana-Farber/Brigham and Women’s Cancer Center; Senior Vice President for Experimental Therapeutics; Professor of Medicine, Harvard Medical School; Director of the Ludwig Center at Dana-Farber/Harvard Cancer Center; Executive Director for Clinical and Translational Research at the Ludwig Institute for Cancer Research
Charles S. Fuchs, MD, MPH
Director, Gastrointestinal Cancer Center, Dana-Farber/Brigham and Women’s Cancer Center; Professor of Medicine, Harvard Medical School
Judy E. Garber, MD, MPH
Director, Center for Cancer Genetics and Prevention, Dana-Farber/Brigham and Women’s Cancer Center; Susan F. Smith Center for Women’s Cancers; Professor of Medicine, Harvard Medical School
Robert Haddad, MD
Disease Center Leader, Head and Neck Oncology Program, Dana-Farber/Brigham and Women’s Cancer Center; Associate Professor of Medicine, Harvard Medical School
Stephen Hodi, Jr., MD
Director, Melanoma Center, Dana-Farber/Brigham and Women’s Cancer Center; Director, Center for Immuno-Oncology; Associate Professor of Medicine, Harvard Medical School
Pasi Jänne, MD, PhD
Director, Lowe Center for Thoracic Oncology, Dana-Farber/Brigham and Women’s Cancer Center: Scientific Director, Belfer Institute for Applied Cancer Science; Professor of Medicine, Harvard Medical School
Tom Kupper, MD
Chairman, Department of Dermatology, Brigham and Women’s Hospital; Disease Center Leader, Cutaneous Oncology; Thomas B. Fitzpatrick Professor of Dermatology, Harvard Medical School
Ursula A. Matulonis, MD
Medical Director, Gynecologic Oncology, Dana-Farber/Brigham and Women’s Cancer Center; Susan F. Smith Center for Women’s Cancers; Associate Professor of Medicine, Harvard Medical School
Geoffrey Shapiro, MD, PhD
Director, Early Drug Development Center, Dana-Farber/Brigham and Women’s Cancer Center; Associate Professor of Medicine, Harvard Medical School
Robert Soiffer, MD
Chief, Hematologic Malignancies, Dana-Farber Cancer Institute; Co-Chief, Stem Cell/Bone Marrow Transplantation Program, Dana-Farber/Brigham and Women’s Cancer Center; Professor of Medicine, Harvard Medical School
Patrick Wen, MD, MBBS
Director, Center for Neuro-Oncology, Dana-Farber/Brigham and Women’s Cancer Center; Professor of Neurology, Harvard Medical School
Eric P. Winer, MD
Chief, Division of Women’s Cancers, Dana-Farber/Brigham and Women’s Cancer Center; Director, Breast Oncology Center; Thompson Senior Investigator in Breast Cancer Research; Susan F. Smith Center for Women’s Cancers; Professor of Medicine, Harvard Medical School
